- Sunday, November 9, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2022 To 2030
Global Estrogen Replacement Therapy Market Overview
Global Estrogen Replacement Therapy Market is estimated to reach USD 48.2 billion by 2030, growing at a CAGR of 7.8% during the forecast period of 2022-2030. It was valued at USD 25.8 billion in 2022. Estrogen Replacement Therapy has been widely used in menopausal women to prevent osteoporosis and coronary heart disease. Estrogen replacement therapy has the following benefits. First, estrogen replacement therapy can significantly relieve the symptoms of the menopausal syndrome, such as facial hot flashes and night sweats. Secondly, estrogen replacement therapy is still the most effective treatment for vaginal and vulvar atrophy in menopausal women. It can improve the pain associated with sexual intercourse, one of the most common causes of sexual apathy in menopausal women. Topical application can achieve curative effects. It has also been found that topical applications can reduce the recurrence rate of urinary tract infections. There is clear evidence of estrogen replacement Therapy can prevent osteoporosis and fractures. However, due to other more effective treatments for osteoporosis, such as Bisphosphonates, estrogen replacement therapy is no longer a first-line drug for preventing osteoporosis. In addition, estrogen replacement therapy also may reduce the incidence of colorectal cancer.Global Estrogen Replacement Therapy Market Insights
The surge in the population of post-menopausal women across the world will accelerate the growth of the global estrogen replacement therapy market in the upcoming periods. Additionally, growing awareness of post-menopausal issues among women, coupled with the growth in drug development for menopausal issues, will fuel the global estrogen replacement therapy market in the next few years. Moreover, the rise in the geriatric population across the world and the various kinds of hormonal changes in the female body predominantly gets affected by the natural process of aging will influence the global estrogen replacement therapy industry in estimated periods. Menopausal women can ease the function of estrogen secretion such as hot flashes, sweating, dizziness, insomnia, irritability, nameless, vaginal dryness, loss of libido, etc. with autonomic disorders based. Furthermore, the swelling awareness about menopausal symptoms among women and the growing treatment opportunities would be projected to fuel the global estrogen replacement therapy market in the future periods. In addition, augmentation in demand to prevent osteoporosis, a consequence of lowered estrogen levels, will surge the global estrogen replacement therapy market in the expected periods.Growth Driver
The growing demand for Estrogen Replacement Therapy to treat the symptoms of menopause
The average age of menopause in normal women is 51 years, and 95% of menopause occurs between 45 and 55 years. Menopause is associated with a significant reduction in ovarian estrogen production. Low post-menopausal estrogen levels may induce vasomotor symptoms (hot flashes), and eventually vulvar vaginal atrophy symptoms, including vaginal dryness and pain during intercourse, namely menopausal genitourinary syndrome (menopause). Estrogen is most effective in alleviating menopausal symptoms, mainly hot flashes, vaginal dryness, and pain during intercourse. Estrogen prevents thinning of the bones (osteoporosis) in menopausal women.Dosages Form Segmental Analysis
Based on dosages form, the global Estrogen Replacement Therapy market classified into Patches, Tablets, Gels/Creams, Suppositories, Implants, and Injections. The Tablets segment predicted to lead the market by 2030, owing to the growing demand tablet ERT for safety concerns and effective long-term therapy. They can reduce or resolve troublesome symptoms of menopause and lower the risk of osteoporosis. The gels/creams segment will drive attributable to estrogen creams absorbed through the skin and go directly into the bloodstream, and they are safer than oral estrogen.Routes of Administration Segmental Analysis
Based on routes of administration, the global Estrogen Replacement Therapy market categorized into Oral, Topical, Subcutaneous Pellets, Injection, and Others. The Oral segment projected to dominate the market as oral is the most preferred option for the patients. It has more favorable effects on lipid profiles, increases sex hormone-binding globulin (SHBG), and increases cortisol-binding globulin. The Topical segment will influence as it is used to treat vaginal dryness, itching, and burning in women who are experiencing menopause.End-User Segmental Analysis
Based on end-user, the global estrogen replacement therapy market classified into Hospitals, Clinics, Pharmacy stores, and Others. Hospitals segment projected to register a higher CAGR by 2030, on account of the surge in the number of women across the globe coupled with the rise in the number of menopausal affected women worldwide. The clinics’ segment provides immediate medicines, and consultation, along with the clinics, helps in the early detection of diseases.Region Segmental Analysis
Based on geography, the global Estrogen Replacement Therapy market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2030, owing to the rising geriatric population, high awareness levels, and the surge in purchasing power of the people coupled with technological innovations in healthcare systems in these regions. The Asia Pacific will drive increasing awareness levels and the rising focus of governments towards the eradication of hormonal deficiencies.Competitor Analysis
Companies such as AbbVie, Inc., Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Novartis AG, Novo Nordisk A/S, Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. are the key players in the Global Estrogen Replacement Therapy Market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Estrogen Replacement Therapy manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to Estrogen Replacement Therapy
- Regulatory bodies
- Suppliers
- Retailers
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 33.65 billion |
| Revenue forecast in 2027 | USD 49.3 billion |
| Growth Rate | CAGR of 5.65% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | AbbVie, Inc., Novartis AG, Novo Nordisk A/S, Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. |
Recent Developments
- In September 2021, Myovant Science & Pfizer Announced FDA Approval for Myfembri® used to manage pain associated with Endometriosis.
- In August 2021, Teva Pharmaceuticals and MedinCell announced the acceptance from the US Food and Drug Administration of TV-46000/MDC-IRM used to treat schizophrenia.
- In March 2021, Theramex announced the completion of decentralized procedure approval from the UK and EU countries for Bijuva® capsules for Hormone Replacement Therapy.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Dosage Forms- Patches
- Tablets
- Gels/Creams
- Suppositories Implants
- Injections
- Oral
- Topical
- Subcutaneous Pellets
- Injections
- Others
- Hospitals
- Clinics
- Pharmacy Store
- Others
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Connected Drug Delivery Devices Market
Southeast Asia Semiconductor Market
Global Anti-Fatigue Mats Market
Automotive Usage-Based Insurance Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Estrogen Replacement Therapy Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Dosage Forms
5.2.1.1. Patches
5.2.1.2. Tablets
5.2.1.3. Gels/Creams
5.2.1.4. Suppositories Implants
5.2.1.5. Injections
5.2.2. By Routes of Administration
5.2.2.1. Oral
5.2.2.2. Topical
5.2.2.3. Subcutaneous Pellets
5.2.2.4. Injections
5.2.2.5. Others
5.2.3. By End-User
5.2.3.1. Hospitals
5.2.3.2. Clinics
5.2.3.3. Pharmacy Store
5.2.3.4. Others
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia-Pacific
5.2.4.4. South America
5.2.4.5. The Middle East & Africa
- North America Estrogen Replacement Therapy Market Overview
6.1. North America Estrogen Replacement Therapy Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Dosage Forms
6.2.1.1. Patches
6.2.1.2. Tablets
6.2.1.3. Gels/Creams
6.2.1.4. Suppositories Implants
6.2.1.5. Injections
6.2.2. By Routes of Administration
6.2.2.1. Oral
6.2.2.2. Topical
6.2.2.3. Subcutaneous Pellets
6.2.2.4. Injections
6.2.2.5. Others
6.2.3. By End-User
6.2.3.1. Hospitals
6.2.3.2. Clinics
6.2.3.3. Pharmacy Store
6.2.3.4. Others
6.2.4. By Country
6.2.4.1. US
6.2.4.2. Canada
6.2.4.3. Mexico
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on North America Estrogen Replacement Therapy Market
- Europe Estrogen Replacement Therapy Market Overview
7.1. Europe Estrogen Replacement Therapy Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Dosage Forms
7.2.1.1. Patches
7.2.1.2. Tablets
7.2.1.3. Gels/Creams
7.2.1.4. Suppositories Implants
7.2.1.5. Injections
7.2.2. By Routes of Administration
7.2.2.1. Oral
7.2.2.2. Topical
7.2.2.3. Subcutaneous Pellets
7.2.2.4. Injections
7.2.2.5. Others
7.2.3. By End-User
7.2.3.1. Hospitals
7.2.3.2. Clinics
7.2.3.3. Pharmacy Store
7.2.3.4. Others
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. UK
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Rest of Europe
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on Europe Estrogen Replacement Therapy Market
- Asia-Pacific Estrogen Replacement Therapy Market Overview
8.1. Asia-Pacific Estrogen Replacement Therapy Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Dosage Forms
8.2.1.1. Patches
8.2.1.2. Tablets
8.2.1.3. Gels/Creams
8.2.1.4. Suppositories Implants
8.2.1.5. Injections
8.2.2. By Routes of Administration
8.2.2.1. Oral
8.2.2.2. Topical
8.2.2.3. Subcutaneous Pellets
8.2.2.4. Injections
8.2.2.5. Others
8.2.3. By End-User
8.2.3.1. Hospitals
8.2.3.2. Clinics
8.2.3.3. Pharmacy Store
8.2.3.4. Others
8.2.4. By Country
8.2.4.1. India
8.2.4.2. Japan
8.2.4.3. Australia
8.2.4.4. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Estrogen Replacement Therapy Market
- South America Estrogen Replacement Therapy Market Overview
9.1. South America Estrogen Replacement Therapy Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Dosage Forms
9.2.1.1. Patches
9.2.1.2. Tablets
9.2.1.3. Gels/Creams
9.2.1.4. Suppositories Implants
9.2.1.5. Injections
9.2.2. By Routes of Administration
9.2.2.1. Oral
9.2.2.2. Topical
9.2.2.3. Subcutaneous Pellets
9.2.2.4. Injections
9.2.2.5. Others
9.2.3. By End-User
9.2.3.1. Hospitals
9.2.3.2. Clinics
9.2.3.3. Pharmacy Store
9.2.3.4. Others
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Estrogen Replacement Therapy Market
- The Middle East & Africa Estrogen Replacement Therapy Market Overview
10.1. The Middle East & Africa Estrogen Replacement Therapy Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Dosage Forms
10.2.1.1. Patches
10.2.1.2. Tablets
10.2.1.3. Gels/Creams
10.2.1.4. Suppositories Implants
10.2.1.5. Injections
10.2.2. By Routes of Administration
10.2.2.1. Oral
10.2.2.2. Topical
10.2.2.3. Subcutaneous Pellets
10.2.2.4. Injections
10.2.2.5. Others
10.2.3. By End-User
10.2.3.1. Hospitals
10.2.3.2. Clinics
10.2.3.3. Pharmacy Store
10.2.3.4. Others
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of the Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Estrogen Replacement Therapy Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. AbbVie, Inc.
11.7.2. Bayer AG
11.7.3. Hisamitsu Pharmaceutical Co., Inc.
11.7.4. Novartis AG
11.7.5. Novo Nordisk A/S
11.7.6. Orion Pharma AB
11.7.7. Pfizer, Inc.
11.7.8. Meda pharmaceuticals
11.7.9. Teva Pharmaceutical Industries Ltd.
11.7.10. TherapeuticsMD
11.7.11. Other Prominent Players
Frequently Asked Questions (FAQ):
The growth rate of the Global Estrogen replacement therapy is 7.8% from 2022 to 2030.
Global Estrogen Replacement Therapy Market is estimated to reach USD 48.2 billion by 2030, valued at USD 25.8 billion in 2022.
Growing drug development for menopausal issues and an increased population of post-menopausal women are the growth drivers of the Global Estrogen replacement therapy.
Hospitals, Clinics, Pharmacy Stores are the end-users of Estrogen replacement therapy products.
AbbVie, Inc., Novartis AG, Novo Nordisk A/S, Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. are the key players in the Global Estrogen replacement therapy.
